New medicine assessment change backed

The NHS should work more closely with manufacturers on assessing the benefits of new medicines rather than simply blocking access, the drug industry believes.

New drugs: UK use is low
New drugs: UK use is low

Dr Richard Barker, director general of the Association of the British Pharmaceutical Industry, said restricting access to drugs led to patients missing out on the best care available.

This means patients cannot be included in many trials and creates a spiral in which care in the UK falls behind that in other countries, he said.

Dr Barker said NICE should recognise that when a drug is launched there may be limited data as to its effectiveness and value to the NHS in practice.

Rather than blocking access, the NHS should be allowed to use the drug and studies undertaken of how patients are benefitting, he said.

The NHS could then, he argued, become a 'living laboratory for healthcare innovation'.

Dr John Jeans, chief operating officer of the Medical Research Council, said the NHS should look at whether it could cut costs simply by checking whether drugs are benefitting particular patients or not.

The health White Paper aims to reform the way that drug companies are paid for NHS medicines.

It hopes a value-based pricing system will improve NHS access to effective drugs and innovative treatment.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GPs unable to veto virtual fitness to practise hearings during pandemic

GPs unable to veto virtual fitness to practise hearings during pandemic

GPs facing fitness to practise investigations during the COVID-19 pandemic will be...

Government rejects major NHSPS overhaul - but changes 'could ease GP service charge disputes'

Government rejects major NHSPS overhaul - but changes 'could ease GP service charge disputes'

A government review has rejected calls for a major overhaul of an NHS Property Services...

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

RCGP urges GPs to collaborate with pharmacies on flu jabs this year

The RCGP and the Royal Pharmaceutical Society have called on GP practices and community...

GP appointments rising fast as COVID-19 cases 'near 10,000 a day'

GP appointments rising fast as COVID-19 cases 'near 10,000 a day'

GP appointments have risen rapidly in recent weeks as schools returned, according...

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

COVID-19 impact on medical schools risks 'serious damage' to future NHS workforce

Medical training and the future NHS workforce could be seriously damaged by the financial...

GPonline's news editor wins medical journalism award

GPonline's news editor wins medical journalism award

GPonline news editor Nick Bostock has won News Story of the Year (specialist media)...